Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Initial phase I results for Large Scale Biology's personalized NHL vaccines

Aug. 12, 2002

ProlX receives SBIR grant to advance HIF inhibitor cancer therapy

Aug. 12, 2002

The CXCR4-CXCL12/SDF-1 pathway is a possible target for non-Hodgkin's lymphoma therapy

Aug. 12, 2002

Novel HDAC inhibitors identified at Beacon

Aug. 9, 2002

Pivotal phase III trial of RSR-13 completes enrollment

Aug. 9, 2002

Little or no activity for KW-2189 in advanced malignant melanoma

Aug. 9, 2002

Servier researchers identify new metalloproteinase inhibitors

Aug. 8, 2002

Bayer claims new PDE10A inhibitors and their use in cancer

Aug. 8, 2002

AstraZeneca completes Iressa NDA for NSCLC

Aug. 8, 2002

Positive results for ursodiol in colorectal cancer

Aug. 8, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...